Last update 20 Mar 2025

Plinabulin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Plinabulin (USAN/INN)
+ [2]
Action
agonists, inhibitors
Mechanism
GEF-H1 agonists(Rho guanine nucleotide exchange factor 2 agonists), KRAS inhibitors(GTPase KRas inhibitors)
Originator Organization
Drug Highest PhasePhase 3
First Approval Date-
RegulationSpecial Review Project (China), Breakthrough Therapy (United States), Priority Review (China)
Login to view timeline

Structure/Sequence

Molecular FormulaC19H20N4O2
InChIKeyUNRCMCRRFYFGFX-TYPNBTCFSA-N
CAS Registry714272-27-2

External Link

KEGGWikiATCDrug Bank
D09655Plinabulin-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeutropeniaPreclinical
China
17 Aug 2021
NeutropeniaPreclinical
China
17 Aug 2021
NeutropeniaPreclinical
China
17 Aug 2021
Non-Small Cell Lung CancerPreclinical
China
29 May 2018
Advanced Lung Non-Small Cell CarcinomaPreclinical
United States
30 Nov 2015
Advanced Lung Non-Small Cell CarcinomaPreclinical
United States
30 Nov 2015
Advanced Lung Non-Small Cell CarcinomaPreclinical
Australia
30 Nov 2015
Advanced Lung Non-Small Cell CarcinomaPreclinical
Australia
30 Nov 2015
Advanced Lung Non-Small Cell CarcinomaPreclinical
United States
30 Nov 2015
Advanced Lung Non-Small Cell CarcinomaPreclinical
Australia
30 Nov 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
39
qoqshuybmi(stpnrqjdlx) = keegvrbkeh lctaxzjshx (qhhgxysspg, hxiircnwuf - rwlbcclauu)
-
12 Nov 2024
Phase 3
Non-Small Cell Lung Cancer
Second line | Third line
EGFR wild-type
559
(cyefqiaqbg) = akbpxlbqoo ztdubqazmr (cfnmrfitfy, 9.34 - 11.87)
Positive
14 Sep 2024
Placebo+Docetaxel
(cyefqiaqbg) = gmwftlnnmj ztdubqazmr (cfnmrfitfy, 8.38 - 10.68)
Phase 3
105
D5W Placebo
(Docetaxel (75 mg/m2) + Pegfilgrastim (6 mg) + Placebo Matching Plinabulin)
(fisaxlywcc) = aiyopgskxx bgtjaqqctc (bklhntevlc, stkdhecmyw - vdebjwkhgt)
-
29 Aug 2024
Saline Placebo+Plinabulin
(Docetaxel (75 mg/m2) + Plinabulin (40 mg) + Placebo Matching Pegfilgrastim)
(fisaxlywcc) = wtyyrjuzpw bgtjaqqctc (bklhntevlc, hhzzkiiajg - qeppaoajlb)
Phase 2
55
Pegfilgrastim+Docetaxel
(Arm 1)
(kogqyozyty) = suivuefgzu dwifsmuvtz (lpijykyqme, fvsdwisjue - acmyoeqdac)
-
16 May 2024
Plinabulin+Docetaxel
(Arm 2)
(kogqyozyty) = jaddcajeod dwifsmuvtz (lpijykyqme, akrdgdzxuw - ehyrejtqgv)
Not Applicable
-
-
cjqdaknntk(qlxejldlif) = towyarmyne eveqolzycq (rqzkbabmwf )
Positive
14 May 2024
cjqdaknntk(qlxejldlif) = oiehfexldp eveqolzycq (rqzkbabmwf )
Not Applicable
15
Plinabulin + pegfilgrastim
aopljtdleh(wlyyjocyyy) = qakypixjpc hpfbgqmwsk (cpiwzcujrt )
-
26 Sep 2023
Phase 2/3
-
(qjzvkngatj) = With Plin, AE frequency of diarrhea was slightly higher (5.2% vs 1%; 1 Gr4 case with Plin), but was manageable, and so was hypertension (11.2% vs 1.7%; all Gr3 cases) vs Plac. Hypertension occurred around the time of infusion and was short-lasting (~2-4 hours) and typically self-limiting. Plin had less AEs of neutropenia (16.4% vs 50.3%) and leukopenia (15.5% vs 38.5%) vs Plac. lrbspuxuvg (ekzfpitjwm )
Positive
31 May 2023
Placebo+Docetaxel
Phase 3
27
baviihygli(ftpohxoqvt) = Plin was superior vs No-Treatment for Doc-induced neutropenia and HC, while maintaining QoL and with minimal AE and bone pain burden smhtfneknp (ggithitsjj )
Positive
01 Mar 2023
Phase 2/3
30
wymfutirdb(ordzhgncrv) = gsargkevlh etojrbpvue (tlitlrxzqx )
Positive
03 Dec 2022
Phase 3
115
Pegfilgrastim+Plinabulin
(jgvpyrqvvi) = kqouzcncxi ojukamncgo (ymqjidxjog )
Positive
21 Oct 2022
Pegfilgrastim
(jgvpyrqvvi) = ynasbbklli ojukamncgo (ymqjidxjog )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free